Search research articles
Contact Us
Filters
Showing results (221-230 of 464) with videos related to
Page
of 47
Sort By:
Journal of Patient-Reported Outcomes
|
November 14, 2023
Qualitative and psychometric evaluation of the PROMIS®-Fatigue SF-7a scale to assess fatigue in patients with moderately to severely active inflammatory bowel disease
Brian G Feagan, William J Sandborn, Bruce E Sands, et al.
Alimentary Pharmacology & Therapeutics
|
April 23, 2020
Development of the symptoms and impacts questionnaire for Crohn's disease and ulcerative colitis
Parambir S Dulai, Vipul Jairath, Reena Khanna, et al.
Physiological Reviews
|
September 27, 2021
Development of antifibrotic therapy for stricturing Crohn's disease: lessons from randomized trials in other fibrotic diseases
Si-Nan Lin, Ren Mao, Chenchen Qian, et al.
Alimentary Pharmacology & Therapeutics
|
October 18, 2019
Declining hospitalisation and surgical intervention rates in patients with Crohn's disease: a population-based cohort
Adam Rahman, Vipul Jairath, Brian G Feagan, et al.
Crohn'S & Colitis 360
|
November 30, 2023
Mirikizumab Improves Quality of Life in Patients With Moderately-to-Severely Active Ulcerative Colitis: Results From the Phase 3 LUCENT-1 Induction and LUCENT-2 Maintenance Studies
Bruce E Sands, Brian G Feagan, Theresa Hunter Gibble, et al.
United European Gastroenterology Journal
|
October 25, 2024
Distinct trajectories of symptomatic response in ulcerative colitis during filgotinib therapy: A post hoc analysis from the SELECTION study
Stefan Schreiber, Brian G Feagan, Edouard Louis, et al.
The Cochrane Database of Systematic Reviews
|
August 9, 2016
Endoscopic scoring indices for evaluation of disease activity in Crohn's disease
Reena Khanna, Sigrid A Nelson, Brian G Feagan, et al.
Alimentary Pharmacology & Therapeutics
|
May 24, 2019
Systematic review with meta-analysis: efficacy and safety of oral Janus kinase inhibitors for inflammatory bowel disease
Christopher Ma, Jeffrey K Lee, Anish R Mitra, et al.
The American Journal of Gastroenterology
|
December 19, 2019
Mongersen (GED-0301) for Active Crohn's Disease: Results of a Phase 3 Study
Bruce E Sands, Brian G Feagan, William J Sandborn, et al.
Inflammatory Bowel Diseases
|
June 28, 2021
Disease Activity Indices for Pouchitis: A Systematic Review
Rocio Sedano, Tran M Nguyen, Ahmed Almradi, et al.
Page
of 47
Search research articles
Search
Showing results (221-230 of 464) with videos related to
Sort By:
Page
of 47
Journal of Patient-Reported Outcomes
|
November 14, 2023
Qualitative and psychometric evaluation of the PROMIS®-Fatigue SF-7a scale to assess fatigue in patients with moderately to severely active inflammatory bowel disease
Brian G Feagan, William J Sandborn, Bruce E Sands, et al.
Alimentary Pharmacology & Therapeutics
|
April 23, 2020
Development of the symptoms and impacts questionnaire for Crohn's disease and ulcerative colitis
Parambir S Dulai, Vipul Jairath, Reena Khanna, et al.
Physiological Reviews
|
September 27, 2021
Development of antifibrotic therapy for stricturing Crohn's disease: lessons from randomized trials in other fibrotic diseases
Si-Nan Lin, Ren Mao, Chenchen Qian, et al.
Alimentary Pharmacology & Therapeutics
|
October 18, 2019
Declining hospitalisation and surgical intervention rates in patients with Crohn's disease: a population-based cohort
Adam Rahman, Vipul Jairath, Brian G Feagan, et al.
Crohn'S & Colitis 360
|
November 30, 2023
Mirikizumab Improves Quality of Life in Patients With Moderately-to-Severely Active Ulcerative Colitis: Results From the Phase 3 LUCENT-1 Induction and LUCENT-2 Maintenance Studies
Bruce E Sands, Brian G Feagan, Theresa Hunter Gibble, et al.
United European Gastroenterology Journal
|
October 25, 2024
Distinct trajectories of symptomatic response in ulcerative colitis during filgotinib therapy: A post hoc analysis from the SELECTION study
Stefan Schreiber, Brian G Feagan, Edouard Louis, et al.
The Cochrane Database of Systematic Reviews
|
August 9, 2016
Endoscopic scoring indices for evaluation of disease activity in Crohn's disease
Reena Khanna, Sigrid A Nelson, Brian G Feagan, et al.
Alimentary Pharmacology & Therapeutics
|
May 24, 2019
Systematic review with meta-analysis: efficacy and safety of oral Janus kinase inhibitors for inflammatory bowel disease
Christopher Ma, Jeffrey K Lee, Anish R Mitra, et al.
The American Journal of Gastroenterology
|
December 19, 2019
Mongersen (GED-0301) for Active Crohn's Disease: Results of a Phase 3 Study
Bruce E Sands, Brian G Feagan, William J Sandborn, et al.
Inflammatory Bowel Diseases
|
June 28, 2021
Disease Activity Indices for Pouchitis: A Systematic Review
Rocio Sedano, Tran M Nguyen, Ahmed Almradi, et al.
Page
of 47